NIOX Group Plc (LON:NIOX) Insider Jonathan Emms Acquires 127,454 Shares

NIOX Group Plc (LON:NIOXGet Free Report) insider Jonathan Emms acquired 127,454 shares of the firm’s stock in a transaction on Tuesday, April 1st. The stock was purchased at an average cost of GBX 8 ($0.10) per share, for a total transaction of £10,196.32 ($13,182.06).

NIOX Group Trading Down 0.8 %

Shares of NIOX Group stock opened at GBX 75.40 ($0.97) on Wednesday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31. The firm has a 50-day moving average of GBX 64.06 and a 200-day moving average of GBX 63.88. NIOX Group Plc has a 52-week low of GBX 57 ($0.74) and a 52-week high of GBX 80 ($1.03). The stock has a market cap of £30.97 billion, a PE ratio of 3,111.63 and a beta of 0.92.

NIOX Group (LON:NIOXGet Free Report) last posted its quarterly earnings data on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. As a group, sell-side analysts forecast that NIOX Group Plc will post 1.1658256 EPS for the current year.

About NIOX Group

(Get Free Report)

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

Featured Articles

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.